CNXU · Company research

Conexeu Sciences Inc. (CNXU): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

14records availableHealthcare

Stock News & Events data

Database-backed records only

14 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
Top Conexeu Sciences (CNXU) Competitors 2026 - MarketBeatTop Conexeu Sciences (CNXU) Competitors 2026 MarketBeatView source ↗MarketBeatOct 8, 2026neutral00.6
A wound-care device candidate is designed to turn liquid into gel in about 10 minutes. - Stock TitanA wound-care device candidate is designed to turn liquid into gel in about 10 minutes. Stock TitanView source ↗Stock TitanOct 6, 2026neutral00.6
Consulting services were paid in shares by Conexeu Sciences (CNXU), priced at $4.75 each. - Stock TitanConsulting services were paid in shares by Conexeu Sciences (CNXU), priced at $4.75 each. Stock TitanView source ↗Stock TitanSep 29, 2026neutral00.6
At $0.001 a share, a Conexeu Sciences (CNXU) executive exercises rights to acquire stock. - Stock TitanAt $0.001 a share, a Conexeu Sciences (CNXU) executive exercises rights to acquire stock. Stock TitanView source ↗Stock TitanSep 28, 2026neutral00.6
$CNXU stock is down 12% today. Here's what we see in our data. - Quiver Quantitative$CNXU stock is down 12% today. Here's what we see in our data. Quiver QuantitativeView source ↗Quiver QuantitativeAug 24, 2026neutral00.6
A $1.6 billion aesthetics segment is studying tissue regeneration - Stock TitanA $1.6 billion aesthetics segment is studying tissue regeneration Stock TitanView source ↗Stock TitanAug 18, 2026neutral00.6
$CNXU stock is up 15% today. Here's what we see in our data. - Quiver Quantitative$CNXU stock is up 15% today. Here's what we see in our data. Quiver QuantitativeView source ↗Quiver QuantitativeAug 14, 2026neutral00.6
Conexeu Sciences (CNXU) Stock Could Be 47.6% Undervalued After FDA Prep And Leadership Moves - Simply Wall StreetConexeu Sciences (CNXU) Stock Could Be 47.6% Undervalued After FDA Prep And Leadership Moves Simply Wall StreetView source ↗Simply Wall StreetJun 21, 2026neutral00.6
Conexeu Sciences (CNXU) Stock Price, News & Analysis - MarketBeatConexeu Sciences (CNXU) Stock Price, News & Analysis MarketBeatView source ↗MarketBeatMay 23, 2026neutral00.6
Conexeu Sciences (Nasdaq:CNXU) - Stock Analysis - Simply Wall StreetConexeu Sciences (Nasdaq:CNXU) - Stock Analysis Simply Wall StreetView source ↗Simply Wall StreetMay 22, 2026neutral00.6
Conexeu Sciences (CNXU) Stock Price, News & Analysis - Stock TitanConexeu Sciences (CNXU) Stock Price, News & Analysis Stock TitanView source ↗Stock TitanMay 21, 2026neutral00.6
Conexeu Sciences Inc. (CNXU) Stock Price, News, Quote & History - Yahoo! Finance CanadaConexeu Sciences Inc. (CNXU) Stock Price, News, Quote & History Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaMay 21, 2026neutral00.6
Conexeu Sciences Inc. (CNXU) stock price, news, quote and history - Yahoo Finance UKConexeu Sciences Inc. (CNXU) stock price, news, quote and history Yahoo Finance UKView source ↗Yahoo Finance UKMay 21, 2026neutral00.6
symbol__ Stock Quote Price and Forecast - CNNsymbol__ Stock Quote Price and Forecast CNNView source ↗CNNMay 19, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.